Back to Journals » Hepatic Medicine: Evidence and Research » Volume 9

Hepatic Medicine: Evidence and Research


Archive: Volume 9, 2017

Efficacy and safety of sofosbuvir-based therapies in patients with advanced liver disease in a real-life cohort

Kutala BK, Mouri F, Castelnau C, Bouton V, Giuily N, Boyer N, Asselah T, Marcellin P

Hepatic Medicine: Evidence and Research 2017, 9:67-73

Published Date: 18 December 2017

PNPLA3 expression and its impact on the liver: current perspectives

Bruschi FV, Tardelli M, Claudel T, Trauner M

Hepatic Medicine: Evidence and Research 2017, 9:55-66

Published Date: 6 November 2017

Impact of hepatitis C virus genotype-4 eradication following direct acting antivirals on liver stiffness measurement

Tag-Adeen M, Sabra AM, Akazawa Y, Ohnita K, Nakao K

Hepatic Medicine: Evidence and Research 2017, 9:45-53

Published Date: 6 October 2017

Hepatitis C infection in Egypt: prevalence, impact and management strategies [Corrigendum]

Gomaa A, Allam N, Elsharkawy A, El Kassas M, Waked I

Hepatic Medicine: Evidence and Research 2017, 9:35-36

Published Date: 26 July 2017

Role of intrafamilial transmission in high prevalence of hepatitis C virus in Egypt

Omar MZ, Metwally MA, El-Feky HM, Ahmed IA, Ismail MA, Idris A

Hepatic Medicine: Evidence and Research 2017, 9:27-33

Published Date: 14 June 2017

Hepatitis C infection in Egypt: prevalence, impact and management strategies

Gomaa A, Allam N, Elsharkawy A, El Kassas M, Waked I

Hepatic Medicine: Evidence and Research 2017, 9:17-25

Published Date: 15 May 2017

Interrelationship of hepatitis C virus genotypes with patient characteristics in Bahrain

Abdulla MA, Murad EA, Aljenaidi HA, Aljowder DR, Aljeeran OIK, Farid E, Al Qamish JR

Hepatic Medicine: Evidence and Research 2017, 9:7-11

Published Date: 1 March 2017

Unresectable hepatoblastoma: current perspectives

Trobaugh-Lotrario AD, Meyers RL, O'Neill AF, Feusner JH

Hepatic Medicine: Evidence and Research 2017, 9:1-6

Published Date: 1 February 2017